A multimethods randomized trial found that plain language versions improved parents' understanding of health recommendations.

COVID-19 Child health Guideline Health recommendations Knowledge mobilization Parents Plain language

Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
09 2023
Historique:
received: 13 01 2023
revised: 02 06 2023
accepted: 23 06 2023
medline: 3 11 2023
pubmed: 9 7 2023
entrez: 8 7 2023
Statut: ppublish

Résumé

To assess the effectiveness of plain language compared with standard language versions of COVID-19 recommendations specific to child health. Pragmatic, allocation-concealed, blinded, superiority randomized controlled trial with nested qualitative component. Trial was conducted online, internationally. Parents or legal guardians (≥18 years) of a child (<18 years) were eligible. Participants were randomized to receive a plain language recommendation (PLR) or standard (SLV) verison of a COVID-19 recommendation specific to child health. Primary outcome was understanding. Secondary outcomes included: preference, accessibility, usability, satisfaction, and intended behavior. Interviews explored perceptions and preferences for each format. Between July and August 2022, 295 parents were randomized; 241 (81.7%) completed the study (intervention n = 121, control n = 120). Mean understanding scores were significantly different between groups (PLR 3.96 [standard deviation (SD) 2.02], SLV 3.33 [SD 1.88], P = 0.014). Overall participants preferred the PLR version: mean rating 5.05/7.00 (95% CI 4.81, 5.29). Interviews (n = 12 parents) highlighted their preference for the PLR and provided insight on elements to enhance future knowledge mobilization of health recommendations. Compared to SLVs, parents preferred PLRs and better understood the recommendation. Guideline developers should strive to use plain language to increase understanding, uptake, and implementation of evidence by the public.

Identifiants

pubmed: 37421995
pii: S0895-4356(23)00165-8
doi: 10.1016/j.jclinepi.2023.06.018
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT05358990']

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-19

Subventions

Organisme : CIHR
ID : GA3-177732
Pays : Canada
Organisme : CIHR
ID : FRN VR4-172741
Pays : Canada
Organisme : CIHR
ID : REC 183,153
Pays : Canada

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts of interest to declare.

Auteurs

Sarah A Elliott (SA)

Alberta Research Centre for Health Evidence, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada; Cochrane Child Health, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.

Shannon D Scott (SD)

Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.

Rana Charide (R)

Departments of Health Research Methods, Evidence and Impact and of Medicine, McMaster University, Hamilton, Ontario, Canada; Michael G. DeGroote and GRADE Centres, McMaster University, Hamilton, Ontario, Canada; WHO Collaborating Center for Infectious Diseases, Research Methods and Recommendations, McMaster University, Hamilton, Ontario, Canada.

Lisa Patterson-Stallwood (L)

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.

Shahab Sayfi (S)

Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.

Ashley Motilall (A)

Departments of Health Research Methods, Evidence and Impact and of Medicine, McMaster University, Hamilton, Ontario, Canada; Michael G. DeGroote and GRADE Centres, McMaster University, Hamilton, Ontario, Canada; WHO Collaborating Center for Infectious Diseases, Research Methods and Recommendations, McMaster University, Hamilton, Ontario, Canada; Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Ami Baba (A)

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.

Tamara Lotfi (T)

Departments of Health Research Methods, Evidence and Impact and of Medicine, McMaster University, Hamilton, Ontario, Canada; Michael G. DeGroote and GRADE Centres, McMaster University, Hamilton, Ontario, Canada; WHO Collaborating Center for Infectious Diseases, Research Methods and Recommendations, McMaster University, Hamilton, Ontario, Canada; Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Jozef Suvada (J)

Departments of Science and International Studies, St. Elizabeth University of Public Health and Social Science, Bratislava, Slovak Republic.

Miloslav Klugar (M)

Czech National Centre for Evidence-Based Healthcare and Knowledge Translation, Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno-Bohunice, Czech Republic.

Tamara Kredo (T)

Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa; Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa; Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.

Joseph L Mathew (JL)

Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Dawn P Richards (DP)

Five02 Labs Inc, Toronto, Ontario, Canada; Canadian Arthritis Patient Alliance, Toronto, Ontario, Canada.

Nancy J Butcher (NJ)

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Martin Offringa (M)

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Neonatology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Kevin Pottie (K)

Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.

Holger J Schünemann (HJ)

Departments of Health Research Methods, Evidence and Impact and of Medicine, McMaster University, Hamilton, Ontario, Canada; Michael G. DeGroote and GRADE Centres, McMaster University, Hamilton, Ontario, Canada; WHO Collaborating Center for Infectious Diseases, Research Methods and Recommendations, McMaster University, Hamilton, Ontario, Canada; Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Lisa Hartling (L)

Alberta Research Centre for Health Evidence, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada; Cochrane Child Health, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. Electronic address: hartling@ualberta.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH